Ellen is Founder and President of CHORD Consulting, which provides product and marketing strategy consulting to innovative companies driving step-change improvements in healthcare.
Ellen has focused her career on developing and commercializing ground-breaking products in life-altering diseases.
She led marketing at Genomic Health, Inc., where she launched the Oncotype DX® Breast Cancer Assay which empowers >80,000 women annually to make better decisions about chemotherapy. As VP of Marketing at Crescendo Bioscience, she launched Vectra DA® to help improve outcomes in rheumatoid arthritis. Ellen began her career at Booz Allen & Hamilton and developed new products at ALZA Corp.
Ellen has an MS in Chemistry and an MBA from Stanford University and a BS from Yale University.